Testicular cancer risk in boys with maldescended testis: a cohort study

J Urol. 1987 Nov;138(5):1214-6. doi: 10.1016/s0022-5347(17)43553-1.

Abstract

Testicular maldescent is considered as a predisposing condition for development of testicular malignancy. Male subjects with a history of cryptorchidism have been suggested by some authors to have a 40 to 50 times increased risk of testis cancer. However, the magnitude of this risk is a point of considerable disagreement. Therefore, we studied the records of 506 consecutive patients hospitalized for maldescended testis from January 1949 to December 1960. Testis cancer developed in 6 patients, which when compared to the 1.3 expectant Danish incidence rate, yielded a statistically significant relative risk of 4.7 (95 per cent confidence interval 1.7 to 10.2). Thus, our study confirmed that male subjects with a history of testicular maldescent have an increased risk for testis cancer, although the magnitude of this risk was lower than suggested previously.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Child
  • Chorionic Gonadotropin / therapeutic use
  • Cryptorchidism / complications*
  • Cryptorchidism / therapy
  • Denmark
  • Dysgerminoma / epidemiology
  • Dysgerminoma / etiology
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal / epidemiology
  • Neoplasms, Germ Cell and Embryonal / etiology
  • Retrospective Studies
  • Risk Factors
  • Testicular Neoplasms / epidemiology*
  • Testicular Neoplasms / etiology
  • Testis / surgery

Substances

  • Chorionic Gonadotropin